JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 243 filers reported holding JUNO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $21,924,000 | -17.2% | 479,640 | -30.4% | 0.06% | -25.3% |
| Q2 2016 | $26,480,000 | +225.9% | 688,876 | +222.9% | 0.08% | +219.2% |
| Q1 2016 | $8,125,000 | -52.8% | 213,323 | -45.5% | 0.03% | -50.0% |
| Q4 2015 | $17,223,000 | +58.5% | 391,693 | +46.6% | 0.05% | +57.6% |
| Q3 2015 | $10,868,000 | -68.1% | 267,098 | -58.2% | 0.03% | -63.3% |
| Q2 2015 | $34,042,000 | -21.3% | 638,325 | -10.4% | 0.09% | -17.4% |
| Q1 2015 | $43,239,000 | +4085.8% | 712,803 | +3502.0% | 0.11% | +3533.3% |
| Q4 2014 | $1,033,000 | – | 19,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |